首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   94360篇
  免费   7020篇
  国内免费   4186篇
耳鼻咽喉   387篇
儿科学   1564篇
妇产科学   912篇
基础医学   14773篇
口腔科学   3066篇
临床医学   7840篇
内科学   16854篇
皮肤病学   1244篇
神经病学   8159篇
特种医学   1668篇
外国民族医学   15篇
外科学   5588篇
综合类   15188篇
现状与发展   25篇
预防医学   5521篇
眼科学   1885篇
药学   11829篇
  13篇
中国医学   3325篇
肿瘤学   5710篇
  2024年   223篇
  2023年   1129篇
  2022年   3000篇
  2021年   3882篇
  2020年   2956篇
  2019年   2547篇
  2018年   2511篇
  2017年   2767篇
  2016年   3136篇
  2015年   3490篇
  2014年   5813篇
  2013年   6587篇
  2012年   5952篇
  2011年   6663篇
  2010年   5254篇
  2009年   5091篇
  2008年   5185篇
  2007年   5083篇
  2006年   4542篇
  2005年   4280篇
  2004年   3482篇
  2003年   2999篇
  2002年   2313篇
  2001年   2004篇
  2000年   1725篇
  1999年   1463篇
  1998年   1375篇
  1997年   1205篇
  1996年   1029篇
  1995年   816篇
  1994年   811篇
  1993年   689篇
  1992年   599篇
  1991年   555篇
  1990年   473篇
  1989年   374篇
  1988年   370篇
  1987年   359篇
  1986年   340篇
  1985年   474篇
  1984年   398篇
  1983年   270篇
  1982年   324篇
  1981年   233篇
  1980年   207篇
  1979年   132篇
  1978年   109篇
  1977年   101篇
  1976年   77篇
  1975年   58篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
宫颈癌对妇女健康构成严重威胁,人乳头瘤病毒感染与宫颈病变及宫颈癌的发生密切相关。关于宫颈癌发生发展的机制仍在研究中。近年研究发现一种多功能核蛋白,即死亡结构域相关蛋白(death domain associated protein,Daxx),其与细胞内蛋白或病毒蛋白相互作用,参与调节细胞凋亡、转录调控、抗病毒等细胞活动,在不同途径中发挥不同的生理或病理作用。通过对Daxx功能及其作用机制的研究有助于进一步阐明宫颈癌发生发展的机制,有助于发现新的预防和治疗方法。综述Daxx的一般特性和研究现况及其在宫颈病变的研究进展。  相似文献   
12.
13.
14.
15.
《The ocular surface》2020,18(4):926-935
PurposeTo visualize and quantify vascular networks in individuals with ocular surface squamous neoplasia (OSSN) through optical coherence tomography angiography (OCTA).MethodCross-sectional study of OSSN patients. Vascular networks were measured by OCTA in the epithelium and sub-epithelial space in the tumors, adjacent tissue, and in the contralateral eye. Vessel area density (VAD, percent of blood vessels within 2.14 mm2), was calculated for each location. Total tumor density (TTD, percent of blood vessels within the entire tumor) was calculated. VAD was assessed separately for corneal and conjunctival locations and compared.ResultsFifteen patients with OSSN were included. The mean age was 61 ± 12 years and the majority were male (80%). The mean tumor area, volume, depth, and TTD were 28.0 ± 9.0 mm2 (range, 10.9–39.7), 9.1 ± 4.1 mm3 (range, 3.4–18.8), 334 ± 125 μm (range, 177–571), and 33.2% ± 11.0% (range, 18.7–58.8), respectively. The VAD was highest within the tumor (28.9% ± 8.7%) followed by the adjacent sub-epithelial tissue and the tissue underneath the conjunctival component of tumor. These densities were higher than the VAD in the tissues of the non-involved eye (all P < 0.05). The VAD within conjunctival component of tumor was significantly higher than those with corneal component (29.8% ± 9.5% vs. 21.1% ± 5.5%, p = 0.006). The VAD under conjunctival tumor was also significantly higher than under corneal component (24.1% ± 7.8% vs. 17.0% ± 6.1%, p = 0.024).ConclusionsOCTA imaging allowed for visualization and quantification of vessel structure and density within, under, and surrounding OSSN.  相似文献   
16.
17.
18.
19.
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase.  相似文献   
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号